|
June 29, 2005
|
Affinergy Awarded Collaborative Funding Grant to Accelerate Research Programs
NC Biotechnology Center and Kenan Institute for Engineering, Technology, & Science to sponsor a Kenan Institute/NC Biotechnology Center Fellow.
RESEARCH TRIANGLE PARK, N.C., June 29, 2005 - Affinergy, Inc., a Duke University spinout with a proprietary site-specific biological delivery system, was recently awarded a Collaborative Funding Grant ("CFG") to support a post-doctoral fellow at Duke University in the laboratory of Dan Kenan, MD, Ph.D., Assistant professor of Pathology in the Department of Pathology and scientific co-founder of Affinergy.
The CFG is a unique program that promotes collaboration between universities and companies to encourage research into new areas that could create new jobs and ultimately improve healthcare outcomes. Four parties contribute resources to the Fellow Program: The North Carolina Biotechnology Center, the Kenan Institute, Duke University, and Affinergy. The goals of the program are to develop and expand technology that originates in universities and has potential commercial value.
"We are grateful for the continued support of the NC Biotech Center as well as the support of the Kenan Institute in helping us develop and commercialize Affinergy's technology," said Dr. Kenan. "This unique program will help sponsor a promising post-doctoral position in a dynamic field of research that has the potential to directly improve the quality of healthcare for many people."
"Affinergy deeply appreciates all of the critical programs supported by the North Carolina Biotechnology Center, including the CGF program," said Peyton Anderson, chief executive officer at Affinergy. "Jobs are created and great companies are built when exciting ideas from our universities are efficiently translated to commercial applications. This program is another example of how the State of North Carolina is actively supporting the transition of university technologies into products and jobs. We look forward to accelerating our research activities and generating additional commercial success through this Collaborative Funding Grant."
About Affinergy, Inc.
Affinergy develops site-specific biological & drug delivery systems using biofriendly binders that selectively adhere to proteins, drugs, cells, and other biomaterial surfaces in order to kickstart biology toward an intended outcome. Affinergy is focused in the orthopedic and biologic drug delivery markets with a growing interest in cardiovascular applications. Affinergy's technology was patented at Duke University and has been incubated at Becton Dickinson's research center in Research Triangle Park. Affinergy was awarded 2005 Innovation of the Year by Frost & Sullivan in the category of Medical Device Coatings.
For more information, visit www.affinergy.com or contact Peyton Anderson at (919) 597-6227.
About The North Carolina Biotechnology Center
The North Carolina Biotechnology Center is a private, non-profit corporation established by the State and supported by the General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business and education statewide.
For more information, please visit www.ncbiotech.org
|
